Corpus Intelligence IC Memo — TEXAS HEALTH HOSPITAL FRISCO 2026-04-26 06:39 UTC
IC Memo — TEXAS HEALTH HOSPITAL FRISCO
Investment Committee Memorandum | TX | 91 beds | Grade C | EBITDA uplift $11.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TEXAS HEALTH HOSPITAL FRISCO

CCN 670260 | COLLIN, TX | 91 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

TEXAS HEALTH HOSPITAL FRISCO is a 91-bed suburban community hospital in COLLIN, TX with $151.3M in net patient revenue and a 8.4% operating margin. The hospital serves a payer mix of 21.0% Medicare, 1.0% Medicaid, and 78.0% commercial.

Thesis: Turnaround. Our ML models identify $11.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.4% to 15.8% (+736bps).

Net Revenue HCRIS$151.3M
Current EBITDA COMPUTED$12.8M
Operating Margin COMPUTED8.4%
Occupancy HCRIS64.9%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS30.8%
Distress Probability ML43.0%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
197
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 8.4% places it above the state median. Among 197 size-comparable peers (46-182 beds), the median margin is 2.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (46-182), prioritizing same-state peers. 197 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TEXAS HEALTH HOSPITAL FRISCO (Target)TX91$151.3M8.4%
ROUND ROCK HOSPITALTX165$681.4M8.7%
THE HEART HOSPITAL BAYLOR PLANTX109$464.6M25.7%
COVENANT CHILDRENS HOSPITALTX181$410.3M15.5%
COLLEGE STATION HOSPITALTX135$397.7M-0.9%
CHILDRENS HOSPITAL OF SAN ANTOTX174$376.5M-2.8%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
MEDICAL CITY MCKINNEYTX166$302.5M-0.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $11.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.2M+210bp18mo
Cost to Collect4.5%2.5%$3.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.8M+122bp9mo
Clean Claim Rate88.0%96.0%$97K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.2M
Cost to Collect
$3.0M
Denial Rate Reduction
$3.0M
A/R Days Reduction
$1.8M
Clean Claim Rate
$97K
Total EBITDA Uplift$11.1M
Current EBITDA$12.8M
+ RCM Uplift+$11.1M
Pro Forma EBITDA$23.9M
Current Margin8.4%
Pro Forma Margin15.8%
WC Released (1x)$5.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$19.7M$195.7M9.95x58.3%
Base (11x exit)10.0x11.0x$19.7M$221.6M11.27x62.3%
Bull Case9.0x11.0x$17.7M$264.8M14.97x71.8%
Bull (12x exit)9.0x12.0x$17.7M$294.1M16.62x75.4%
Bear Case11.0x10.0x$21.6M$133.6M6.18x43.9%
Bear (11x exit)11.0x11.0x$21.6M$154.0M7.12x48.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 197 hospitals with 46-182 beds
  • Same-state prioritization (n=198)
  • Comp margins: P25=-10.9% / P50=2.4% / P75=11.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.